Telomir Pharmaceuticals is a pioneering biotech company dedicated to advancing age-reversal science and exploring the potential of telomere biology to combat aging and age-related diseases. The company’s mission centres on developing innovative therapeutics that address the cellular mechanisms behind aging, with the ultimate goal of improving healthspan and promoting longevity.

At the heart of Telomir’s research is Telomir-1, a groundbreaking small molecule designed to lengthen telomeres—the protective end caps of DNA strands. By targeting telomere shortening, a key factor in cellular aging and the onset of degenerative diseases, Telomir Pharmaceuticals aims to unlock novel approaches to age management for both humans and animals.

Telomir combines cutting-edge science with a focus on safety, innovation, and rigorous research. With a team of leading scientists and industry experts, the company is committed to pushing the boundaries of what is possible in the field of longevity therapeutics. Through its pioneering work, Telomir seeks to transform how we approach aging and redefine what it means to live a healthy, extended life.